Clinical Trial Update: Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficiency of bevacizumab for pulmonary fibrosis induced by acute radiation and chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Pulmonary Fibrosis | Phase 2 | Status: UNKNOWN